Cepharanthine

N/A

Report date: 2024/11/22 16:57:34

Base Information

Drug NameCepharanthine
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHIV replication inhibitorsImmunomodulatorsApoptosis stimulants +[4] 
TargetsNuclear factor NF-kappa-B complex
Therapy Area/IndicationsNeoplasmsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesKaken Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKaken Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsNeoplasmsHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A